Multicenter Comparison of Four Automated Immunoassay Analyzers for Prostate Specific Antigen

참고문헌 (10)

1. Bozeman CB, "Treatment of chronic prostatitis lowers serum prostate specific antigen", J Urol, 167, pp.1723~1726 (2002)
2. Sturgeon C, "Tietz textbook of clinical chemistry and molecular diagnostics", pp.437~478 (2018), Elsevier
3. Boccon-Gibod L, "Management of prostate-specific antigen relapse in prostate cancer : a European Consensus", Int J Clin Pract, 58, pp.382~390 (2004)
4. Kort SA, "Comparison of 6 automated assays for total and free prostate-specific antigen with special reference to their reactivity toward the WHO 96", 670 reference preparation, 2006, pp.52, 1568~1574
5. Critz FA, "Post-treatment PSA < or=0.2 ng", mL defines disease freedom after radiotherapy for prostate cancer using modern techniques, 1999, pp.54, 968~971
6. Moul JW, "Prostate specific antigen only progression of prostate cancer", J Urol, 163, pp.1632~1642 (2000)
7. Gheiler EL, "Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer", Urology, 51, pp.789~795 (1998)
8. Roach M 3rd, "Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference", Int J Radiat Oncol Biol Phys, 65, pp.965~964 (2006)
9. Ang M, "Men presenting with prostate-specific antigen (PSA) values of over 100 ng", mL, 2016, pp.117(S4), 68~75
10. Gontero P, "Radical prostatectomy for PSA> or =100 ng", mL prostate cancer, 2008, pp.54, 957~958

관련 논문AI추천